Affordable and Accessible
Medicines for a Better Future

An impact investment opportunity
>

Affordable and Accessible
Medicines for a Better Future

An impact investment opportunity
>

Affordable & Accessible
Medicines for a
Better Future

An impact investment opportunity

Our Company

Singapore Biotech is a trusted biosimilar
pharmaceutical company that changes lives
by making quality treatments more
accessible and more affordable.

What Is A Biosimilar?

A biosimilar is a complex biologic which is highly
similar to branded medicines. Biosimilars are
increasing access to advanced biologics for patients
around the world.

 

An Impact Investment Opportunity

Singapore Biotech focuses on bringing medicines into frontier markets at affordable prices to offer hope to people previously ignored. In order to develop the highest quality medicines possible, we maintain industry leading, sustainable manufacturing practices and attract the best talent regardless of race and gender. Our biosimilar medicines greatly contribute to advancing social progress by improving global health.

 

Our Medicines

Neurology


CinnoVex

ReciGen

Gynaecology
& Endocrinology


Cinnal-f

CinnaTropin

Rheumatology


CinnoPar

CinnoRA

Altebrel

 

 

At Singapore Biotech, we are proud to be recognized as one of the top research-based companies in the world.
We are passionate about driving innovation and have one of the largest pipelines of biosimilar medicines in development.

 

Contact Us

 

© Singapore Biotechnology, Pte. Ltd. All rights reserved.